Tag:
Compugen
Latest Headlines
Latest Headlines
Computer-based discovery biotech from Israel lands in Bay Area
Tel Aviv-based Compugen has opened shop in a promised land of biotech, South San Francisco.
Shulman: Best biotech stocks to own
This morning, MarketWatch's Michael Shulman listed some of what he sees are the hottest bargain biotech stocks for this year: Cerus, Curis, Compugen, Spectrum Pharmaceuticals and Impax Laboratories.
Compugen protein "abolishes" relapses in MS animal study
Shares of Israel's Compugen were buoyed late last week after the developer said that one of its experimental therapies was able to "completely abolish" spontaneous relapses of multiple sclerosis in
In silico cancer fighter comes to life
Researchers have discovered and validated a drug target for fighting multiple cancers following the in silico prediction via a Compugen discovery platform for monoclonal antibody targets. CGEN-671--a
Compugen shares rise on Pfizer pact
Shares of Compugen spiked in premarket trading when the biotech announced that it had struck a deal to collaborate with Pfizer on three new drug candidates. But investors were reacting largely on
Discovery platform yields peptide prediction hit
The technology behind Compugen's recent announcement of positive therapeutic effects of a novel peptide in an animal study of inflammatory bowel disease is the company's Disease-Associated
ALSO NOTED: FDA OKs human thrombin; A new cancer research company; Compugen inks drug pact; and much more...
> Shares of Omrix surged this morning on the news that the FDA had approved Evithrom, a protein used to control bleeding during surgery. This is the first human thrombin to gain approval since
